Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy

Force Generation via β-Cardiac Myosin, Titin, and α-Actinin Drives Cardiac Sarcomere Assembly from Cell-Matrix Adhesions

(2018) Anant Chopra et al.   DEVELOPMENTAL CELL

Genetic Etiology for Alcohol-Induced Cardiac Toxicity

(2018) James S. Ware et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Management of Cancer Therapeutics–Related Cardiac Dysfunction

(2018) Ajay Vallakati et al.   Heart Failure Clinics

The first titin (c.59926 + 1G > A) founder mutation associated with dilated cardiomyopathy

(2017) Edgar T. Hoorntje et al.   EUROPEAN JOURNAL OF HEART FAILURE

Truncating Titin ( TTN) Variants in Chemotherapy-Induced Cardiomyopathy

(2017) M. Linschoten et al.   JOURNAL OF CARDIAC FAILURE

Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

(2017) Saro H. Armenian et al.   JOURNAL OF CLINICAL ONCOLOGY

Truncating Variants in Titin Independently Predict Early Arrhythmias in Patients With Dilated Cardiomyopathy

(2017) Upasana Tayal et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Genome-wide association and pathway analysis of left ventricular function after anthracycline exposure in adults

(2017) Quinn S. Wells et al.   Pharmacogenetics and Genomics

Cardio-oncology: Gaps in Knowledge, Goals, Advances, and Educational Efforts

(2017) Gina Biasillo et al.   Current Oncology Reports

Genetics and genomics of dilated cardiomyopathy and systolic heart failure

(2017) Upasana Tayal et al.   Genome Medicine

Advanced Heart Failure Therapies for Cancer Therapeutics–Related Cardiac Dysfunction

(2017) Christopher M. Bianco et al.   Heart Failure Clinics

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

(2016) Jose Luis Zamorano et al.   EUROPEAN HEART JOURNAL

Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples

(2016) Roddy Walsh et al.   GENETICS IN MEDICINE

Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study

(2016) Saro H. Armenian et al.   JOURNAL OF CLINICAL ONCOLOGY

Genetic basis of familial dilated cardiomyopathy patients undergoing heart transplantation

(2016) Sofia Cuenca et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Clinical and Mechanistic Insights Into the Genetics of Cardiomyopathy

(2016) Michael A. Burke et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Titin-truncating variants affect heart function in disease cohorts and the general population

(2016) Sebastian Schafer et al.   NATURE GENETICS

Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies

(2016) James S. Ware et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy

(2015) D. Cardinale et al.   CIRCULATION

Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity

(2015) Eric S. Christenson et al.   CLINICAL BIOCHEMISTRY

Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease

(2015) Angharad M. Roberts et al.   Science Translational Medicine

Atlas of the clinical genetics of human dilated cardiomyopathy

(2014) Jan Haas et al.   EUROPEAN HEART JOURNAL

Hyaluronan Synthase 3 Variant and Anthracycline-Related Cardiomyopathy: A Report From the Children's Oncology Group

(2014) Xuexia Wang et al.   JOURNAL OF CLINICAL ONCOLOGY

Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

(2014) J. C. Plana et al.   European Heart Journal-Cardiovascular Imaging

Cancer Therapy–Induced Cardiotoxicity: Basic Mechanisms and Potential Cardioprotective Therapies

(2014) Virginia Shalkey Hahn et al.   Journal of the American Heart Association

Genetics in dilated cardiomyopathy

(2013) Pablo Garcia-Pavia et al.   Biomarkers in Medicine

Validation of variants inSLC28A3andUGT1A6as genetic markers predictive of anthracycline-induced cardiotoxicity in children

(2013) H. Visscher et al.   PEDIATRIC BLOOD & CANCER

Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines

(2012) G. Curigliano et al.   ANNALS OF ONCOLOGY

Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab

(2012) Heloisa Sawaya et al.   Circulation-Cardiovascular Imaging

A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff

(2012) Pablo Cingolani et al.   FLY

Truncations of Titin Causing Dilated Cardiomyopathy

(2012) Daniel S. Herman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Case of Epirubicin-Induced Cardiomyopathy in Familial Cardiomyopathy

(2011) Kate E. Shipman et al.   JOURNAL OF CLINICAL ONCOLOGY

Familial dilated cardiomyopathy: another risk factor for anthracycline-induced cardiotoxicity?

(2010) Maarten P. van den Berg et al.   EUROPEAN JOURNAL OF HEART FAILURE

Genetic polymorphisms in the carbonyl reductase 3 geneCBR3 and the NAD(P)H:quinone oxidoreductase 1 geneNQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer

(2008) Javier G. Blanco et al.   CANCER

Cardiac assessment of limb–girdle muscular dystrophy 2I patients: An echography, Holter ECG and magnetic resonance imaging study

(2008) Karim Wahbi et al.   NEUROMUSCULAR DISORDERS